Eigen value analysis of HIV-1 integrase inhibitors

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Virology

Background:

• HIV-1 integrase is a key target for antiretroviral therapy.
• Understanding structure-activity relationships is crucial for designing potent inhibitors.
• Existing inhibitors target different steps of the integrase enzymatic activity.

Purpose of the Study:

• To develop a 3D quantitative structure-activity relationship (QSAR) model for HIV-1 integrase inhibitors.
• To evaluate the predictive performance of models based on different computational methods.
• To identify key structural features influencing inhibitor activity against HIV-1 integrase.

Main Methods:

• Applied the eigenvalue analysis (EVA) paradigm for 3D QSAR.
• Utilized a training set of 35 HIV-1 integrase inhibitors from diverse structural classes.
• Employed semiempirical calculations (MOPAC AM1 and PM3) for normal-mode frequencies.
• Validated models using a test set of 6 hydrazide inhibitors.

Main Results:

• Models derived using the AM1 method demonstrated strong internal and external predictivity.
• High predictive accuracy was achieved for both the 3"-processing (r(2)(cv) = 0.806, r(2)(pred) = 0.761) and 3"-strand transfer (r(2)(cv) = 0.677, r(2)(pred) = 0.591) steps.
• The AM1-based model showed good generalization to a novel structural class.

Conclusions:

• The developed 3D QSAR model using EVA and AM1 calculations is predictive of HIV-1 integrase inhibitor activity.
• This approach can guide the design of novel and effective antiretroviral agents.
• The study highlights the importance of computational methods in drug discovery for HIV-1.